EFTA00804470.pdf

Report Status: Partial ra—40 j Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR8391 ION Client #: 78300020 56W5265 EPSTEIN, JEFFREY Requisition: 0006872 MOSKOWITZ,BRUCE W DOB: 01/20/1953 AGE: 65 BRUCE MOSKOWITZ,MD Gender: M Attn: NATIONWIDE ACCOUNT Collected: 11/23/2018 Phone: 561.366.0084 1411 N FLAGLER DR STE 7100 Received: 11/23/2018 / 21:23 EST Patient ID: 19530120MJE WEST PALM BEACH,FL 33401.3418 Reported: 11/24/2018 / 06:36 EST Health ID: 8573003290851249 Test Nana In Range Out Of Range Reference Range Lab PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM MI PROTEIN, TOTAL 7.1 6.1-8.1 g/dL LIPID PANEL, STANDARD CHOLESTEROL, TOTAL 216 H <200 mg/dL MI HOL CHOLESTEROL 23 L >40 mg/dL MI TRIGLYCERIDES 935 H <150 mg/dL MI LDL—CHOLESTEROL mg/dL (talc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 9.4 H <5.0 (talc) MI NON HDL CHOLESTEROL 193 H <130 mg/dL (talc) MI For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 111 H 65-99 mg/dL Fasting reference interval For someone without known diabetes, a glucose value between 100 and 125 mg/dL is consistent with prediabetes and should be confirmed with a follow-up test. UREA NITROGEN (BUN) 20 7-25 mg/dL CREATININE 0.95 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 84 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 97 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (talc) SODIUM 138 135-146 mmol/L POTASSIUM 4.4 3.5-5.3 mmolife CHLORIDE 105 98-110 mmol/L CLIENTSERVICES:866.6971378 SPECIMEN: MR839110N PAGEI0F4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804470  Report Status: Partial Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR8391 ION Client #: 78300020 EPSTEIN, JEFFREY Collected: 11/23/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 11/23/2018 / 21:23 EST Gender: M Reported: 11/24/2018 106:36 EST Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab CARBON DIOXIDE 24 20-32 mmol/L CALCIUM 9.9 8.6-10.3 mg/dL PROTEIN, TOTAL 7.1 6.1-8.1 g/dL ALBUMIN 4.4 3.6-5.1 g/dL GLOBULIN 2.7 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.6 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.7 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 60 40-115 U/L AST 23 10-35 U/L ALT 36 9-46 U/L HEMOGLOBIN Ale 5.7 R <5.7 % of total Hgb MI For someone without known diabetes, a hemoglobin Ale value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Ale targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Ale for diagnosis of diabetes for children. URIC ACID 6.9 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 2.44 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.6 4.9-10.5 mcg/dL MI FREE T4 INDEX (T7) 2.3 1.4-3.8 T3 UPTAKE 30 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 11 < OR = 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 6.0 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.28 4.20-5.80 Million/uL HEMOGLOBIN 15.4 13.2-17.1 g/dL HEMATOCRIT 44.3 38.5-50.0 % MCV 83.9 80.0-100.0 fL MCH 29.2 27.0-33.0 pg MCHC 34.8 32.0-36.0 g/dL RDW 13.0 11.0-15.0 % PLATELET COUNT 273 140-400 Thousand/uL MPV 10.6 7.5-12.5 fL ABSOLUTE NEUTROPHILS 2892 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2298 850-3900 cells/uL ABSOLUTE MONOCYTES 492 200-950 cells/uL ABSOLUTE EOSINOPHILS 270 15-500 cells/uL ABSOLUTE BASOPHILS 48 0-200 cells/uL NEUTROPHILS 48.2 LYMPHOCYTES 38.3 MONOCYTES 8.2 CLIENTSERIIICES:866.6971378 SPECIMEN: MR839110N PAGE 2 OF 4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804471  Report Status: Partial Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation Specimen: MR83911ON Client #: 78300020 EPSTEIN, JEFFREY Collected: 11/23/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 11/23/2018 / 21:23 EST Gender: M Reported: 11/24/2018 / 06:36 EST Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab EOSINOPHILS 4.5 BASOPHILS 0.8 IRON AND TOTAL IRON MI BINDING CAPACITY IRON, TOTAL 91 50-180 mcg/dL IRON BINDING CAPACITY 336 250-425 mcg/dL (calc) % SATURATION 27 15-60 % (calc) PSA, TOTAL 0.6 < OR = 4.0 ng/mL MI The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391 ION PAGE30F4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804472  Report Status: Partial j Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR8391 ION Client #: 78300020 EPSTEIN, JEFFREY Collected: 11/23/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 11/23/2018 / 21:23 EST Gender: M Reported: 11/24/2018 1 06:36 EST Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab ' VITAMIN D,25-OH,TOTAL,IA 24 L 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: httpJ/education.questdiagnostics.com/faq/FAO163 (This link is being provided for informational/ educational purposes only.) Physician Comments: PENDING TESTS: PROTEIN ELECTROPHORESIS FERRMN HS CRP VITAMIN B12 HOMOCYSTEINE C-REACTIVE PROTEIN CALCIUM, IONIZED MERCURY. BLOOD IMMUNOFIXATION, SERUM TESTOSTERONE FREE (DIALYSIS) AND TOTAL.MS URINALYSIS, COMPLETE PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. HMO COMMERCE PARKWAY. MIRAMAR. FL MOIS.39.18 Laboratocc Outdo': JULIE I. FRIEDMAN.MD.CLIA. IOD0277312 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391I0N PAGE 4 OF 4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804473